{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:03:40Z","timestamp":1792015420940,"version":"4.4.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,14]],"date-time":"2027-01-14T00:00:00Z","timestamp":1799884800000},"content-version":"am","delay-in-days":288,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25ek0109621h0003"],"award-info":[{"award-number":["JP25ek0109621h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.coi.2025.102719","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T01:25:22Z","timestamp":1768353922000},"page":"102719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A critical look at animal and cellular models in autoinflammatory diseases"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9488-661X","authenticated-orcid":false,"given":"Yohei","family":"Kirino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Takeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2025.102719_bib1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.immuni.2011.02.020","article-title":"Gain-of-function Pyrin mutations induce NLRP3 protein-independent interleukin-1beta activation and severe autoinflammation in mice","volume":"34","author":"Chae","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2025.102719_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051105","article-title":"Genetic loss of murine pyrin, the Familial Mediterranean Fever protein, increases interleukin-1beta levels","volume":"7","author":"Hesker","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2025.102719_bib3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1097-2765(03)00056-X","article-title":"Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis","volume":"11","author":"Chae","year":"2003","journal-title":"Mol Cell"},{"key":"10.1016\/j.coi.2025.102719_sbref4","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1093\/rheumatology\/keaf336","article-title":"M694I variant of MEFV drives pathogenesis of familial Mediterranean fever through enhanced Th17 cell differentiation","volume":"64","author":"Koga","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.coi.2025.102719_bib5","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2009.05.005","article-title":"Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity","volume":"30","author":"Brydges","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2025.102719_bib6","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.immuni.2009.04.012","article-title":"A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses","volume":"30","author":"Meng","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2025.102719_bib7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/cei\/uxad097","article-title":"A novel Nlrp3 knock-in mouse model with hyperactive inflammasome in development of lethal inflammation","volume":"215","author":"Zhou","year":"2024","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coi.2025.102719_bib8","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-01866-6","article-title":"Slc6a3-dependent expression of a CAPS-associated Nlrp3 allele results in progressive behavioral abnormalities and neuroinflammation in aging mice","volume":"17","author":"von Herrmann","year":"2020","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.coi.2025.102719_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1084\/jem.20040435","article-title":"Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases","volume":"200","author":"Xanthoulea","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2025.102719_bib10","doi-asserted-by":"crossref","first-page":"9801","DOI":"10.1073\/pnas.0914118107","article-title":"Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome","volume":"107","author":"Simon","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2025.102719_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.926175","article-title":"TRAPS mutations in Tnfrsf1a decrease the responsiveness to TNFalpha via reduced cell surface expression of TNFR1","volume":"13","author":"Akagi","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102719_sbref12","doi-asserted-by":"crossref","DOI":"10.1172\/JCI193011","article-title":"UBA1-depleted neutrophils disrupt immune homeostasis and induce VEXAS-like autoinflammatory disease in mice","volume":"135","author":"Dong","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2025.102719_bib13","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1093\/rheumatology\/keaf284","article-title":"Recapitulation of clinical features in a patient-derived xenograft mouse model of VEXAS syndrome","volume":"64","author":"Arede","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.coi.2025.102719_sbref14","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41591-025-03623-9","article-title":"Mechanisms of hematopoietic clonal dominance in VEXAS syndrome","volume":"31","author":"Molteni","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2025.102719_bib15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/art.1780380321","article-title":"Excessive function of peripheral blood neutrophils from patients with Behcet's disease and from HLA-B51 transgenic mice","volume":"38","author":"Takeno","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coi.2025.102719_bib16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","article-title":"Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)","volume":"27","author":"Masters","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coi.2025.102719_bib17","first-page":"21","article-title":"Behcet's disease-like symptoms induced by the Herpes simplex virus in ICR mice","volume":"8","author":"Sohn","year":"1998","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.coi.2025.102719_bib18","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/art.38359","article-title":"Systemic juvenile idiopathic arthritis-like syndrome in mice following stimulation of the immune system with Freund's complete adjuvant: regulation by interferon-gamma","volume":"66","author":"Avau","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2025.102719_bib19","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1210\/endo.142.11.8511","article-title":"Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis","volume":"142","author":"De Benedetti","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.coi.2025.102719_bib20","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1084\/jem.191.2.313","article-title":"Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice","volume":"191","author":"Horai","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2025.102719_bib21","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1073\/pnas.1035999100","article-title":"IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist","volume":"100","author":"Nakae","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2025.102719_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34480-6","article-title":"mTORC1 links pathology in experimental models of Still's disease and macrophage activation syndrome","volume":"13","author":"Huang","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2025.102719_bib23","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1172\/JCI43157","article-title":"Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice","volume":"121","author":"Behrens","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2025.102719_bib24","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/ajmg.a.38326","article-title":"Drug discovery and development for rare genetic disorders","volume":"173","author":"Sun","year":"2017","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.coi.2025.102719_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22126360","article-title":"Monogenic autoinflammatory diseases: state of the art and future perspectives","volume":"22","author":"Di Donato","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coi.2025.102719_bib26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41584-021-00614-1","article-title":"Molecular mechanisms of phenotypic variability in monogenic autoinflammatory diseases","volume":"17","author":"Aksentijevich","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.coi.2025.102719_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.pmbts.2024.07.019","article-title":"Current progress in CRISPR-Cas systems for rare diseases","volume":"210","author":"Israr","year":"2025","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.coi.2025.102719_bib28","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.4049\/jimmunol.1002720","article-title":"Differential expression of NLRP3 among hematopoietic cells","volume":"186","author":"Guarda","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2025.102719_bib29","doi-asserted-by":"crossref","first-page":"7941","DOI":"10.1073\/pnas.1818281116","article-title":"Hierarchy of clinical manifestations in SAVI N153S and V154M mouse models","volume":"116","author":"Motwani","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2025.102719_bib30","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1038\/s41423-025-01355-x","article-title":"An animal model of NLRC4-associated autoinflammation and infantile enterocolitis reveals novel therapeutic strategies","volume":"22","author":"Wang","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.coi.2025.102719_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75917-6","article-title":"A zebrafish functional genomics model to investigate the role of human A20 variants in vivo","volume":"10","author":"Cultrone","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2025.102719_bib32","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s003350010082","article-title":"Isolation, genomic organization, and expression analysis of the mouse and rat homologs of MEFV, the gene for familial mediterranean fever","volume":"11","author":"Chae","year":"2000","journal-title":"Mamm Genome"},{"key":"10.1016\/j.coi.2025.102719_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.870535","article-title":"Induced pluripotent stem cell-derived monocytes\/macrophages in autoinflammatory diseases","volume":"13","author":"Tanaka","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102719_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237030","article-title":"Induced pluripotent stem cell-derived monocytic cell lines from a NOMID patient serve as a screening platform for modulating NLRP3 inflammasome activity","volume":"15","author":"Seki","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2025.102719_sbref35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41590-025-02088-9","article-title":"Mechanisms of NLRP3 activation and inhibition elucidated by functional analysis of disease-associated variants","volume":"26","author":"Feng","year":"2025","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2025.102719_bib36","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/art.41743","article-title":"Somatic mutations in UBA1 define a distinct subset of relapsing polychondritis patients with VEXAS","volume":"73","author":"Ferrada","year":"2021","journal-title":"Syndr Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2025.102719_bib37","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/art.42471","article-title":"Novel somatic UBA1 variant in a patient with VEXAS syndrome","volume":"75","author":"Stiburkova","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2025.102719_bib38","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1038\/s41375-025-02775-4","article-title":"Distinct characteristics of VEXAS-causative UBA1 M41 and recurrent functional non-M41 mutations","volume":"39","author":"Sakuma","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.coi.2025.102719_bib39","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","article-title":"Behcet's disease","volume":"341","author":"Sakane","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2025.102719_bib40","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ng.625","article-title":"Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease","volume":"42","author":"Remmers","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2025.102719_bib41","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ng.2520","article-title":"Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B*51 and ERAP1","volume":"45","author":"Kirino","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2025.102719_bib42","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.624","article-title":"Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet's disease susceptibility loci","volume":"42","author":"Mizuki","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2025.102719_bib43","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1136\/annrheumdis-2015-209059","article-title":"A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behcet's disease in HLA-B*51 carriers","volume":"75","author":"Takeuchi","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102719_bib44","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1136\/ard-2022-222852","article-title":"EULAR study group on 'MHC-I-opathy': identifying disease-overarching mechanisms across disciplines and borders","volume":"82","author":"Kuiper","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102719_bib45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/ng.3459","article-title":"Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease","volume":"48","author":"Zhou","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2025.102719_bib46","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-019-1928-5","article-title":"Haploinsufficiency of A20 caused by a novel nonsense variant or entire deletion of TNFAIP3 is clinically distinct from Behcet's disease","volume":"21","author":"Tsuchida","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.coi.2025.102719_sbref47","first-page":"1718","article-title":"Distinct features of trisomy 8-associated autoinflammatory disease from Behcet's disease: case series and systematic review","volume":"43","author":"Ichikawa","year":"2025","journal-title":"Clin Exp Rheumatology"},{"key":"10.1016\/j.coi.2025.102719_bib48","doi-asserted-by":"crossref","first-page":"14405","DOI":"10.1073\/pnas.2002051117","article-title":"Common genetic susceptibility loci link PFAPA syndrome, Behcet's disease, and recurrent aphthous stomatitis","volume":"117","author":"Manthiram","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2025.102719_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.852297","article-title":"The roles of monocytes and macrophages in Behcet's disease with focus on M1 and M2 polarization","volume":"13","author":"Hirahara","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2025.102719_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109318","article-title":"Neutrophil, NETs and Behcet's disease: a review","volume":"250","author":"Le Joncour","year":"2023","journal-title":"Clin Immunol"},{"key":"10.1016\/j.coi.2025.102719_bib51","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-018-1613-0","article-title":"GWAS-identified CCR1 and IL10 loci contribute to M1 macrophage-predominant inflammation in Behcet's disease","volume":"20","author":"Nakano","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.coi.2025.102719_bib52","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMra2305712","article-title":"Behcet's syndrome","volume":"390","author":"Saadoun","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2025.102719_bib53","doi-asserted-by":"crossref","first-page":"9680","DOI":"10.1074\/jbc.M117.789180","article-title":"The Behcet's disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing","volume":"292","author":"Guasp","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2025.102719_bib54","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1136\/ard-2022-222277","article-title":"Behcet's disease risk-variant HLA-B51\/ERAP1-Hap10 alters human CD8 T cell immunity","volume":"81","author":"Cavers","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102719_bib55","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1056\/NEJMoa2004114","article-title":"RNA identification of PRIME cells predicting rheumatoid arthritis flares","volume":"383","author":"Orange","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2025.102719_sbref56","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ard.2025.05.295","article-title":"Op0285\u2005multi-omics analysis integrated with prospective registry data identifies Rnase1 associated with disease activity in Vexas syndrome","volume":"84","author":"Kirino","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2025.102719_sbref57","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1093\/rheumatology\/keae530","article-title":"Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry","volume":"64","author":"Kirino","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.coi.2025.102719_sbref58","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1354969","article-title":"Association of high disease activity and serum IL-6 levels with the incidence of inflammatory major organ events in Behcet disease: a prospective registry study","volume":"15","author":"Hirahara","year":"2024","journal-title":"Front Immunol"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525001955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525001955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:35:53Z","timestamp":1784540153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791525001955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":58,"alternative-id":["S0952791525001955"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2025.102719","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A critical look at animal and cellular models in autoinflammatory diseases","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2025.102719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102719"}}